COVID-19: Vaccines and Therapeutics

Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices that adults ages 65 years and older receive an additional updated 2023-2024 COVID-19 vaccine dose. 
When joined together, emergency prep and routine immunizations can be an effective way to mobilize community members to make healthy choices for their future selves.
A CDC study released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and older.
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23 flu season, defined as receiving a bivalent booster dose or completing a primary series in the previous two months, and fewer than half of…
Children under age 12 should receive a 0.25 milliliter dose of the 2023-24 Moderna COVID-19 vaccine, not the full vial for that age group, the Food and Drug Administration reminded health care providers recently.
The Department of Health and Human Services Oct. 27 urged Merck and Pfizer to work with private insurers to maintain access to their COVID-19 oral antiviral medications as they transition from federal to commercial distribution, beginning Nov. 1.
To enjoy a healthy Thanksgiving with family and friends, get vaccinated against the flu and COVID-19. That’s the message of AHA’s latest United Against the Flu social media toolkit for hospitals and health systems. Download the toolkit here.
The Department of Health and Human Services’ Administration for Strategic Preparedness and Response recently awarded over $500 million to prepare for clinical trial three COVID-19 vaccine candidates that target better or longer-lasting immune response; increase central laboratory capacity for…
The Department of Health and Human Services in November will begin transitioning to commercial distribution an estimated 7.9 million treatment courses of the COVID-19 antiviral pill Paxlovid under an agreement with Pfizer announced. 
The AHA has excellent resources to help hospital and health system teams encourage patients and people in their communities to get vaccinated against the flu, COVID-19 and RSV.